The Archive · 2 posts
Discover new possibilities in health with Poolbeg Pharma (POLB) – pioneering infectious disease treatments and listed on the LSE. 💡
Poolbeg Pharma reports FY25 results with POLB 001 trial progress, cash runway to 2027, and interim data expected this summer.
Showing 1 of 2 posts
Poolbeg Pharma's POLB 001 Phase 2 in cancer immunotherapy & oral GLP-1 for obesity. AI pipeline, Friel's leadership & 2026 catalysts analysed.
JoshuaMay 20, 2025
April 28, 2026